Preferred Label : pregnancy trimester, first;
MeSH definition : The beginning third of a human PREGNANCY, from the first day of the last normal menstrual
period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation.;
MeSH synonym : first pregnancy trimesters; pregnancy trimesters, first; phase, early placental; placental phase, early; pregnancy, first trimester; first trimester pregnancies; pregnancies, first trimester; trimester, first; trimesters, first; early placental phase; first pregnancy trimester; early placental phases; placental phases, early; phases, early placental; first trimester; first trimesters; first trimester pregnancy;
MeSH annotation : human only; check tags HUMANS & FEMALE & PREGNANCY; DF: PREGN TRIMESTER FIRST; human only;
Origin ID : D011261;
UMLS CUI : C0032979;
Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
The beginning third of a human PREGNANCY, from the first day of the last normal menstrual
period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation.
https://www.reseau-naissance.fr/medias/2025/02/RSN-REF_011-INFORMATIONS-a-aborder-au-T1.pdf
2025
France
popular works
pregnancy trimester, first
first trimester pregnancy
---
https://www.cochrane.org/fr/CD014715/PREG_precision-de-lechographie-du-premier-et-du-deuxieme-trimestre-pour-lidentification-des-anomalies
2024
United Kingdom
review of literature
french abstract
Intervention Not Given for Kawasaki Disease
KIT Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
Unemployed
Nitric Oxide Measurement
American College of Cardiology/American Heart Association Lesion Complexity Score
A
NF1 Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
History of Medical Treatment Absent
Has No Sibling
Additional Surgery for New Tumor Event Absent
Tumor Reoccurrence Absent After Initial Treatment
First Trimester
Adjuvant Post-operative Immunological Therapy Was Not Administered
Accuracy
IDH Family Wildtype
asthenia
First Degree Family History Cancer Negative
Regional Anesthesia was not Administered
Choose
Drug Accumulation 1.2 to 1.99
International Prognostic Index Low Risk Group
Medication Not Taken
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Gestational Complication
Tumor Progression Absent After Initial Treatment
No History of Congenital Heart Disease
Pregnancy
Ultrasound Mode
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Additional Molecular Studies Were Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
NON Mouse
IV Anesthesia was not Administered
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
RET Rearrangement Analysis Was Not Performed
pregnancy trimester, first
Not Lost to Follow-Up
Patient was not Postmenopausal with no Prior Oophorectomy
Ultrasound
De-Identification
Chief Complaint was Not Witnessed
ERBB2 Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
New Tumor Event After Initial Treatment Absent
No History of Kawasaki Disease
Routine Cytogenetics Were not Completed
EGFR Gene Amplification Negative
fetus, nos
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Adjuvant Post-operative Radiation Therapy Was Not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ultrasonography, nos
ALK Rearrangement Analysis Was Not Performed
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
pregnancy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Minor Criteria for Rheumatic Heart Disease Not Present
defect, nos
Chemical/Occupational Exposure Absent
PTEN Gene Mutation Negative
Neither Case or Control Status
IDH Family Mutation Analysis Was Not Performed
No History of Myopathy
Cancer History Absent
No Response to Intervention for Kawasaki Disease
Low Risk
Evidence of Disease Absent after Completion of Therapy
Documentation Absent
fetal ultrasonography
Caffeine Not Routinely Consumed
Family History of Stomach Cancer Absent
pregnancy, high-risk
Therapeutic Ionizing Radiation to Head History Absent
MET Mutation Analysis Was Not Performed
Abnormality
EGFR Amplification Analysis Was Not Performed
ATRX Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Norway
pregnancy, nos
Chemotherapy Not Received
Other Preoperative IV Medications were not Administered
Analytical Procedure Precision
Regardless
First Degree Family History Thyroid Cancer Negative
No Known History of Illicit Drug Use
Patient was Not Previously Evaluated for Current Chief Complaint
Exposure as Collected Occurrence
SDH Complex Mutation Analysis Was Not Performed
Negation
No History of Neonatal Complication
Molecular Genetic Variation
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Preoperative IV Antiemetics were not Administered
Ultrasonogram
Fluorescence In Situ Hybridization Was Not Performed
Abnormal Indicator
ATRX Gene Mutation Negative
New Disease is not Multifocal
Selenium and Vitamin E Efficacy Trial
First Degree Family History of Primary Brain Tumor Negative
Fetus
Petal
Neither
Ultrasound Imaging
Adjuvant I-131 Therapy Negative
PDGFRA Mutation Analysis Was Not Performed
Preoperative IV Antacids were not Administered
Radiation History Negative
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
ultrasonography, prenatal
Intercurrent Illness is Absent at Onset of Chief Complaint
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Unspecified
History of Colorectal Cancer Negative
Any Metastatic Diagnosis Absent
1p/19q Deletion Analysis Was Not Performed
Chief Complaint Not Caused by Trauma
Another Form of Birth Control was not Used
No Known History of Alcohol Use
Hypertension Absent
Radiation Therapy Not Received
IPSS-R Risk Category Low
Local Anesthesia Agents were not Administered
Preoperative IV Sedation was Not Administered
EGFR Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
Paraneoplastic Syndrome is Not Present
Preoperative IV Opiates were not Administered
TP53 Mutation Analysis Was Not Performed
Nitric Oxide
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
MGMT Promoter Methylation Testing Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
BRAF Rearrangement Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
Disease Risk Index Low Risk
NRAS Mutation Analysis Was Not Performed
No History of Rheumatic Fever
No History of Non-Cardiac Surgery
KRAS Mutation Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Regular Smokeless Tobacco Use for Six Weeks or More Negative
risk
Analytical Procedure Accuracy
Physician Diagnosed Diabetes Absent
10q23/PTEN Locus Deletion Analysis Was Not Performed
BRAF Mutation Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
---
https://www.cochrane.org/fr/CD006712/FERTILREG_les-anesthesiques-locaux-sont-ils-efficaces-pour-le-traitement-de-la-douleur-lors-dune-interruption
2024
United Kingdom
review of literature
french abstract
Voluntary Report
What Month is it
pain management
withholding treatment
abortion, legal
pregnancy trimester, first
administration, topical
First Trimester
anesthetics, local
Tiaprofenic Acid
first trimester pregnancy
local anesthesia, nos
Treatment Interruption
local anesthetic, nos
Discontinue
Local Anesthesia Procedure
Pain Therapy
pain
abortion on demand
elective abortion
---
https://dumas.ccsd.cnrs.fr/dumas-04247402
2023
France
dissertations, academic
metrorrhagia
Systematic Review
Metrorrhagia
metrorrhagia
review literature as topic
First Trimester
classification
Reviewing
pregnancy trimester, first
---
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467896
2020
false
false
false
France
coronavirus infections
pneumonia, viral
child
journal article
alberta
hospitals, pediatric
Intertrochanteric fracture
pregnancy trimester, first
central
pandemics
comparative study
hospital, nos
Intercondylar fracture of the humerus
data collection
pediatrician
COVID-19
---
http://www.sudoc.fr/249164108
2020
France
dissertations, academic
hospitals
mother, nos
Child
pregnancy complications
children's hospital
Child
data collection
Child
metrorrhagia
complication, nos
Metrorrhagia
breast
Child
metrorrhagia
child
pregnancy trimester, first
hospitals, pediatric
hospitals
child
---
https://www.ansm.sante.fr/actualites/ondansetron-zophren-et-generiques-ne-doit-pas-etre-utilise-pendant-le-premier-trimestre-de-la-grossesse-pour-traiter-les-nausees-et-vomissements-post-operatoires-ou-lies-a-une-chimiotherapie
2019
false
false
false
France
French
pharmacovigilance note
ondansetron
Contraindications, Drug
pregnancy trimester, first
stomatognathic system abnormalities
ondansetron
postoperative nausea and vomiting
nausea
vomiting
chemotherapy-induced nausea and vomiting
abnormalities, drug-induced
teratogens
antiemetics
---
https://hal-anses.archives-ouvertes.fr/anses-02177731
2019
France
technical report
pregnancy trimester, first
france
antibiotic, nos
Outcome Assessment, Health Care
Antibiotics
Induced fracture
resulting in
anti-bacterial agents
drug, nos
France
France
France
french
eating, nos
France
antibiotics
food analysis
food, nos
Food
---
https://ansm.sante.fr/uploads/2021/01/06/dhpc-191213-ondansetron.pdf
2019
false
false
false
France
French
ondansetron
antiemetics
pregnancy trimester, first
Contraindications, Drug
abnormalities, drug-induced
teratogens
stomatognathic system abnormalities
pharmacovigilance note
ondansetron
nausea
vomiting
antineoplastic agents
radiotherapy
postoperative nausea and vomiting
serotonin 5-HT3 receptor antagonists
---
https://www.sggg.ch/fileadmin/user_upload/57_franz_Risikospezifizierung_Praeeklampsie.pdf
2019
false
false
false
Switzerland
pregnancy trimester, first
pre-eclampsia
switzerland
risk assessment
guideline
pre-eclampsia
risk
---
http://www.jogc.com/article/S1701-2163(16)39330-6/abstract
2016
false
Canada
French
pregnancy complications
ultrasonography, prenatal
pregnancy trimester, first
practice guideline
---
https://dumas.ccsd.cnrs.fr/dumas-01412230
2016
false
false
false
France
French
dissertations, academic
pregnancy
sports
motor activity
pregnancy trimester, first
---
http://campus.cerimes.fr/gynecologie-et-obstetrique/enseignement_cycle3/metrorragies1/index.htm
false
true
3eme cycle / doctorat
France
French
audiovisual aids
case reports
pregnancy trimester, first
metrorrhagia
abortion, induced
---
http://archives.uness.fr/sites/umvf/media/ressMereEnfant/SON/sonu-complications1erT/index.htm
2012
false
true
false
true
France
pregnancy trimester, first
pregnancy
abortion, spontaneous
pregnancy complications
pregnancy complications
pregnancy complications
pregnancy complications
pregnancy complications
pregnancy, ectopic
audiovisual aids
pregnancy complications
---
http://dumas.ccsd.cnrs.fr/dumas-00669496
2012
false
true
false
France
dissertations, academic
pregnancy trimester, first
hyperemesis gravidarum
---
http://www.cochrane.org/fr/CD003037
2010
false
true
false
France
United Kingdom
abortion, induced
treatment outcome
obstetric surgical procedures
review of literature
french abstract
pregnancy trimester, first
pharmaceutical preparations
pregnancy
---
https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/Fr/15_Mifepristone_2008.pdf
2008
Switzerland
guideline
pregnancy trimester, first
expert testimony
drug, nos
mifepristone
Acanthocytosis
pharmaceutical preparations
first trimester pregnancy
disruption, nos
expert opinion
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/le-depistage-prenatal-du-syndrome-de-down-et-dautres-aneuploidies-au-premier-trimestre-de-la-grossesse.html
2003
false
Canada
French
diagnostic uses of chemicals
health technology assessment
down syndrome
age factors
Biomarkers
Outcome and Process Assessment, Health Care
ultrasonography, prenatal
ultrasonography, prenatal
pregnancy trimester, second
predictive value of tests
chorionic gonadotropin
prenatal diagnosis
medical staff
prenatal diagnosis
genetic testing
down syndrome
aneuploidy
quebec
down syndrome
technology assessment, biomedical
fetus
informed consent
false positive reactions
false negative reactions
diagnostic techniques and procedures
down syndrome
prenatal diagnosis
down syndrome
prenatal diagnosis
Biomarkers
pregnancy
pregnancy trimester, first
ultrasonography, prenatal
amniocentesis
chorionic villi sampling
genetic counseling
public opinion
guidelines
government publications
technical report
comparative study
treatment outcome
down syndrome
---
https://www.jogc.com/article/S1701-2163(16)30681-8/abstract
2003
false
Canada
French
ultrasonography, prenatal
pregnancy
ultrasonography, prenatal
abortion, threatened
abortion, incomplete
cerclage, cervical
pregnancy, multiple
hydatidiform mole
pelvic inflammatory disease
genetic counseling
genetic testing
practice guideline
gestational age
pregnancy trimester, first
chorionic villi sampling
pregnancy, ectopic
embryonic and fetal development
journal article
Evidence-Based medicine
---
